High-flow nasal cannula therapy reduced the respiratory rate and respiratory distress in a standard model simulator and in patients with hypoxemic respiratory failure

High-flow nasal cannula (HFNC) therapy has been increasingly applied to treat patients with severe hypoxemic respiratory failure. We investigated whether vital signs reflect the reduction of work of breathing in a simulator study and a clinical study. In the simulator study, a standard model high-fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Motoyasu, Akira, Moriyama, Kiyoshi, Okano, Hiromu, Yorozu, Tomoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804361/
https://www.ncbi.nlm.nih.gov/pubmed/31635493
http://dx.doi.org/10.1177/1479973119880892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804361/
https://www.ncbi.nlm.nih.gov/pubmed/31635493
http://dx.doi.org/10.1177/1479973119880892

Ejemplares similares